Cytodyn Inc (CYDY)

[stockorus]

Most likely the PR today was already in the works well before FDA letter; perhaps they decided to release it ahead of time, with urgency, given the action of FDA yesterday. Either the foreign agencies had asked for a Topline report focused on the critical patients, or Cytodyn proposed to provide such a report and the agencies agreed. And we were making progress and this topline report could have been an important next step.

FDA through its action however pushed itself in the middle and now there is really a lot of clean-up work that Cytodyn and its foreign friends have to do. The foreign agencies are also in a difficult position. We have submitted the report probably as per a mutually accepted plan; but their consideration may have turned lukewarm since yesterday. Lot depends on the type of contact and channels we have already established with them and how Cytodyn can work through them and keep their interest alive.